Back
MEI Pharma Vs. Revance Therapeutics Industry Stock Comparison
Buy
68
MEIP
MEI Pharma
Last Price:
3.14
Seasonality Move:
4.15%
Sell
4
RVNC
Revance Therapeutics
Last Price:
4.13
Seasonality Move:
7.02%
Buy
68
MEI Pharma (MEIP)
is a Buy
Is MEI Pharma a Buy, Sell or Hold?
- The current MEI Pharma [MEIP] share price is $3.13. The Score for MEIP is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- MEIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
4
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $3.44. The Score for RVNC is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MEIP Stock Price Chart
What is MEI Pharma's stock price today?
-
The MEI Pharma share price today is $3.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
MEIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 65.21 | Buy |
| Chaikin Money Flow: | 8226 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.7 - 3.06) | Buy |
| Bollinger Bands (100): | (2.78 - 3.28) | Buy |
RVNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 22.01 | Sell |
| Chaikin Money Flow: | -4360846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.71 - 5.93) | Sell |
| Bollinger Bands (100): | (3.48 - 6.32) | Sell |
MEIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.06 | Buy |
| 20-day SMA: | 2.92 | Buy |
| 50-day SMA: | 2.93 | Buy |
| 200-day SMA: | 3.33 | Sell |
| 8-day EMA: | 3.05 | Buy |
| 20-day EMA: | 2.98 | Buy |
| 50-day EMA: | 2.97 | Buy |
| 200-day EMA: | 3.64 | Sell |
RVNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.26 | Sell |
| 20-day SMA: | 5.33 | Sell |
| 50-day SMA: | 5.62 | Sell |
| 200-day SMA: | 4.66 | Sell |
| 8-day EMA: | 4.89 | Sell |
| 20-day EMA: | 5.25 | Sell |
| 50-day EMA: | 5.33 | Sell |
| 200-day EMA: | 6.2 | Sell |
MEI Pharma Earnings Growth & MEIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.63 per share.
MEI Pharma Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revance Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||